Sol-Gel Technologies Crecimiento futuro

Future controles de criterios 2/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Sol-Gel Technologies de 57% y 60.1% respectivamente, mientras que el BPA crecerá en un 57.3% al año.

Información clave

57.0%

Tasa de crecimiento de los beneficios

57.3%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Pharmaceuticals	22.8%
Tasa de crecimiento de los ingresos	60.1%
Rentabilidad financiera futura	n/a
Cobertura de analistas	Low
Última actualización	13 Mar 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Will Sol-Gel Technologies (NASDAQ:SLGL) Spend Its Cash Wisely?

Feb 28

Here's Why We're Watching Sol-Gel Technologies' (NASDAQ:SLGL) Cash Burn Situation

Nov 07

Companies Like Sol-Gel Technologies (NASDAQ:SLGL) Are In A Position To Invest In Growth

Jul 21

Sol-Gel Technologies GAAP EPS of $0.01 beats by $0.11, revenue of $3.5M misses by $1.11M

Aug 04

These Analysts Think Sol-Gel Technologies Ltd.'s (NASDAQ:SLGL) Sales Are Under Threat

May 17

We Think That There Are Issues Underlying Sol-Gel Technologies' (NASDAQ:SLGL) Earnings

Apr 15

Downgrade: Here's How Analysts See Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Performing In The Near Term

Apr 05

We Think Sol-Gel Technologies (NASDAQ:SLGL) Can Afford To Drive Business Growth

Nov 23

We Think Sol-Gel Technologies (NASDAQ:SLGL) Needs To Drive Business Growth Carefully

Aug 04

Here's Why Sol-Gel Technologies Ltd.'s (NASDAQ:SLGL) CEO May Deserve A Raise

Jul 01

Sol-Gel says no FDA notification regarding its marketing application for EPSOLAY

Apr 27

Newsflash: Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Analysts Have Been Trimming Their Revenue Forecasts

Mar 05

We're Not Very Worried About Sol-Gel Technologies' (NASDAQ:SLGL) Cash Burn Rate

Feb 02

What Type Of Returns Would Sol-Gel Technologies'(NASDAQ:SLGL) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Dec 29

FDA accepts Sol-Gel application for Twyneo

Dec 07

Sol-Gel: Slow And Steady Topical Technology

Nov 19

These Analysts Think Sol-Gel Technologies Ltd.'s (NASDAQ:SLGL) Sales Are Under Threat

Nov 18

Sol-Gel Technologies EPS beats by $0.09, beats on revenue

Nov 12

Previsiones de crecimiento de beneficios e ingresos

NasdaqGM:SLGL - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2026	8	-13	-14	-11	1
12/31/2025	6	-14	-16	-13	1
12/31/2024	2	-20	-20	-17	1
12/31/2023	2	-27	-18	-18	N/A
9/30/2023	1	-28	N/A	N/A	N/A
6/30/2023	1	-26	-11	-11	N/A
3/31/2023	5	-20	N/A	N/A	N/A
12/31/2022	4	-15	-10	-9	N/A
9/30/2022	25	5	N/A	N/A	N/A
6/30/2022	33	10	-3	-3	N/A
3/31/2022	31	2	N/A	N/A	N/A
12/31/2021	31	3	-8	-8	N/A
9/30/2021	13	-17	N/A	N/A	N/A
6/30/2021	6	-27	-27	-27	N/A
3/31/2021	6	-26	N/A	N/A	N/A
12/31/2020	9	-29	-26	-25	N/A
9/30/2020	11	-29	N/A	N/A	N/A
6/30/2020	13	-28	-20	-19	N/A
3/31/2020	20	-26	N/A	N/A	N/A
12/31/2019	23	-25	-23	-22	N/A
9/30/2019	19	-30	N/A	N/A	N/A
6/30/2019	14	-30	-29	-28	N/A
3/31/2019	6	-32	N/A	N/A	N/A
12/31/2018	0	-32	-25	-23	N/A
9/30/2018	0	-26	N/A	N/A	N/A
6/30/2018	0	-32	-23	-21	N/A
3/31/2018	0	-32	N/A	N/A	N/A
12/31/2017	0	-32	-26	-24	N/A
9/30/2017	N/A	-31	N/A	-22	N/A
6/30/2017	N/A	-24	N/A	-22	N/A
3/31/2017	N/A	-22	N/A	N/A	N/A
12/31/2016	N/A	-21	N/A	-18	N/A
12/31/2015	N/A	-10	N/A	-8	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Se prevé que SLGL siga sin ser rentable en los próximos 3 años.

Beneficios vs. Mercado: Se prevé que SLGL siga sin ser rentable en los próximos 3 años.

Beneficios de alto crecimiento: Se prevé que SLGL siga sin ser rentable en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (60.1% al año) de SLGL crezcan más rápidamente que los del mercado US (7.9% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos (60.1% al año) de SLGL crezcan más rápidamente que un 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de SLGL se prevé que sea elevada dentro de 3 años.

Sol-Gel Technologies Crecimiento futuro

Future controles de criterios 2/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Consensus revenue estimates increase by 13%, EPS downgraded

Consensus revenue estimates decrease by 15%

Consensus revenue estimates decrease by 38%, EPS upgraded

Consensus revenue estimates decrease by 69%, EPS upgraded

Price target decreased by 28% to US$10.50

Consensus revenue estimates decrease by 36%, EPS upgraded

Recent updates

Consensus revenue estimates increase by 13%, EPS downgraded

Full year 2023 earnings: EPS in line with analyst expectations despite revenue beat

Will Sol-Gel Technologies (NASDAQ:SLGL) Spend Its Cash Wisely?

Consensus revenue estimates decrease by 15%

Sol-Gel Technologies Ltd. Announces Resignation of Shmuel Ben Zvi from Board

Now 24% undervalued after recent price drop

Consensus revenue estimates decrease by 38%, EPS upgraded

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Here's Why We're Watching Sol-Gel Technologies' (NASDAQ:SLGL) Cash Burn Situation

Consensus revenue estimates decrease by 69%, EPS upgraded

Price target decreased by 28% to US$10.50

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Sol-Gel Technologies Ltd. Appoints Sharon Kochan to the Board of Directors

Companies Like Sol-Gel Technologies (NASDAQ:SLGL) Are In A Position To Invest In Growth

Consensus revenue estimates decrease by 36%, EPS upgraded

Co-Founder notifies of intention to sell stock

Sol-Gel Technologies Ltd., Annual General Meeting, Jul 26, 2023

Consensus revenue estimates increase by 42%, EPS downgraded

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Consensus revenue estimates increase by 72%, EPS downgraded

Full year 2022 earnings: EPS and revenues miss analyst expectations

Investor sentiment deteriorates as stock falls 16%

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Price target decreased to US$12.50

Insufficient new directors

Investor sentiment deteriorated over the past week

Consensus revenue estimates increase by 20%

Price target increased to US$19.00

Price target increased to US$18.00

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Sol-Gel Technologies GAAP EPS of $0.01 beats by $0.11, revenue of $3.5M misses by $1.11M

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Consensus revenue estimates increase by 33%

These Analysts Think Sol-Gel Technologies Ltd.'s (NASDAQ:SLGL) Sales Are Under Threat

Consensus forecasts updated

Insufficient new directors

Sol-Gel Technologies Announces FDA Approval of EPSOLAY

We Think That There Are Issues Underlying Sol-Gel Technologies' (NASDAQ:SLGL) Earnings

Sol-Gel Technologies Announces the Commercial Availability of TWYNEO

Sol-Gel Technologies Ltd., Annual General Meeting, May 19, 2022

Downgrade: Here's How Analysts See Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Performing In The Near Term

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Consensus revenue estimates fall by 45%

Forecast to breakeven in 2021

Sol-Gel Technologies Announces Positive Update Related to FDA Review Status of EPSOLAY®

Consensus forecasts updated

We Think Sol-Gel Technologies (NASDAQ:SLGL) Can Afford To Drive Business Growth

Price target decreased to US$17.75

Third quarter 2021 earnings released: EPS US$0.056 (vs US$0.38 loss in 3Q 2020)

Second quarter 2021 earnings released: US$0.35 loss per share (vs US$0.31 loss in 2Q 2020)

We Think Sol-Gel Technologies (NASDAQ:SLGL) Needs To Drive Business Growth Carefully

Consensus forecasts updated

Chief Financial Officer notifies of intention to sell stock

Here's Why Sol-Gel Technologies Ltd.'s (NASDAQ:SLGL) CEO May Deserve A Raise

Consensus revenue estimates increase to US$17.4m

Consensus forecasts updated

First quarter 2021 earnings released: US$0.18 loss per share (vs US$0.33 loss in 1Q 2020)

Forecast breakeven pushed back to 2024

Sol-Gel Technologies Provides Update on FDA Review of Epsolay®

Sol-Gel says no FDA notification regarding its marketing application for EPSOLAY

Analysts lower revenue estimates to US$16.8m

Full year 2020 earnings released: US$1.30 loss per share (vs US$1.26 loss in FY 2019)

Revenue beats expectations, earnings disappoint

Newsflash: Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Analysts Have Been Trimming Their Revenue Forecasts

New 90-day low: US$8.90

We're Not Very Worried About Sol-Gel Technologies' (NASDAQ:SLGL) Cash Burn Rate

New 90-day high: US$10.09

What Type Of Returns Would Sol-Gel Technologies'(NASDAQ:SLGL) Shareholders Have Earned If They Purchased Their SharesYear Ago?